LEADER 01211nam  2200361Ka 450 
001 9910697356603321
005 20080905150343.0
035   $a(CKB)5470000002387366
035   $a(OCoLC)243474338
035   $a(EXLCZ)995470000002387366
100   $a20080811d2008      ua             0
101 0 $aspa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 03$aEl ana?lisis del anti?geno prosta?tico especi?fico (PSA)$b[electronic resource] $epreguntas y respuestas
210  1$a[Bethesda, Md.] :$cNational Cancer Institute,$d[2008]
215   $a9 pages $cdigital, PDF file
225 1 $aHojas informativas ;$v5.29s
300   $aTitle from title screen (viewed on Aug. 11, 2008).
300   $a"5/21/08."
517   $aAna?lisis del anti?geno prosta?tico especi?fico 
606   $aProstate-specific antigen
606   $aCancer$xTreatment
615  0$aProstate-specific antigen.
615  0$aCancer$xTreatment.
712 02$aNational Cancer Institute (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697356603321
996   $aEl ana?lisis del anti?geno prosta?tico especi?fico (PSA)$93445438
997   $aUNINA